Cellular and humoral biomarkers of Bronchopulmonary Dysplasia.
Sign Up to like & getrecommendations! Published in 2017 at "Early human development"
DOI: 10.1016/j.earlhumdev.2016.12.003
Abstract: The pathogenesis of Bronchopulmonary Dysplasia (BPD) is multifactorial and the clinical phenotype of BPD is extremely variable. Predicting BPD is difficult, as it is a disease with a clinical operational definition but many clinical phenotypes… read more here.
Keywords: bronchopulmonary dysplasia; biomarkers bronchopulmonary; humoral biomarkers; cellular humoral ... See more keywords
Early Biomarkers of Bronchopulmonary Dysplasia: A Quick Look to the State of the Art
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Perinatology"
DOI: 10.1055/s-0042-1758867
Abstract: Abstract Bronchopulmonary dysplasia (BPD) is one of the most common pulmonary sequelae of extreme preterm birth, with long-lasting respiratory symptoms and reduced lung function. A reliable predictive tool of BPD development is urgent and its… read more here.
Keywords: early biomarkers; dysplasia quick; biomarkers bronchopulmonary; dysplasia ... See more keywords
Pilot feasibility study to detect mesenchymal stem cell biomarkers of bronchopulmonary dysplasia in the tracheal aspirate fluid of preterm infants.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of neonatal-perinatal medicine"
DOI: 10.3233/npm-181722
Abstract: OBJECTIVE This study aimed to detect novel mesenchymal stem cell peptides/biomarkers of bronchopulmonary dysplasia (BPD) in the tracheal aspirate fluid (TAF) of preterm infants. STUDY DESIGN Participants included infants less than 32 weeks' gestational age… read more here.
Keywords: stem cell; biomarkers bronchopulmonary; preterm infants; mesenchymal stem ... See more keywords